FLAURA Archives - Medical Conferences

First-line osimertinib significantly lengthens OS in NSCLC

Presented By

Prof. Suresh Ramalingam, Emory University, Atlanta, USA

Trial

Phase 3, FLAURA

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 21:05

Systemic therapy of brain metastases

Presented By

Dr Natasha Leighl, Dr Edrune Arriola Aperribay

Trial

Phase 3, FLAURA, ALEX, ALTA-1L, AURA3

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 08:09

PD-L1 expression in untreated EGFR-mutant non-small-cell lung cancer and response to osimertinib

Presented By

Prof. Suresh Ramalingam, Emory University School of Medicine, Winship Cancer Institute, USA

Trial

Phase 3, FLAURA

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 23:21

EGFR-targeted treatments

Presented By

Dr Céline Mascaux, Aix-Marseille University, France

Trial

IPASS, FLAURA

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 23:26

ALK inhibition, guidelines, liquid biopsies, and immunotherapy

Presented By

Dr Céline Mascaux, Aix-Marseille University, France

Trial

AURA3, FLAURA

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 22:31